Tao Wu

Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4

Zhongxing Liang, Tao Wu, Hong Lou et al. · Cancer Research · 2004 · 337 citations

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial

Xiangrui Meng, Tao Wu, Yonggui Hong et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 82 citations

Second-line Treatment, Oncology, Esophageal Cancer +6

Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases

Oscar Lopez‐Nunez, Ivy John, Ryane N. Panasiti et al. · Modern Pathology · 2019 · 65 citations · Full text

Molecular Characterization, Surgical Pathology, Histopathology +3

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

Munawar Anwar, Qitong Chen, Dengjie Ouyang et al. · Clinical Cancer Research · 2021 · 52 citations · Full text

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

Qitong Chen, Dengjie Ouyang, Munawar Anwar et al. · Frontiers in Oncology · 2020 · 52 citations · Full text